CDCP1 Antibodies

Santa Cruz Biotechnology provides a broad selection of CDCP1 monoclonal antibodies for investigating CDCP1 in various biological processes. CDCP1 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CDCP1, or CUB domain-containing protein 1, is a transmembrane protein that plays a significant role in cell adhesion, migration, and signaling pathways. Research has shown CDCP1's involvement in cancer progression and metastasis, making it a critical target for therapeutic interventions. Understanding CDCP1 function can provide insights into tumor biology and potential treatment strategies. Researchers worldwide utilize CDCP1 monoclonal antibodies to explore cellular mechanisms and pathways. Advanced research techniques combined with high-quality CDCP1 monoclonal antibodies enable deeper understanding of cellular processes. Multiple applications and consistent performance make CDCP1 monoclonal antibodies essential tools for cancer research. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific knowledge and developing potential therapeutic strategies.